 | • レポートコード：MRC2-11QY05034 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、93ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料はウイルスベクター製造のグローバル市場について調査・分析したレポートです。種類別（アデノウイルスベクター、アデノ随伴ウイルスベクター、レトロウイルスベクター、レンチウイルスベクター、その他）市場規模、用途別（遺伝子治療、ワクチン）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別ウイルスベクター製造の競争状況、市場シェア ・世界のウイルスベクター製造市場：種類別市場規模 2015年-2020年（アデノウイルスベクター、アデノ随伴ウイルスベクター、レトロウイルスベクター、レンチウイルスベクター、その他） ・世界のウイルスベクター製造市場：種類別市場規模予測 2021年-2026年（アデノウイルスベクター、アデノ随伴ウイルスベクター、レトロウイルスベクター、レンチウイルスベクター、その他） ・世界のウイルスベクター製造市場：用途別市場規模 2015年-2020年（遺伝子治療、ワクチン） ・世界のウイルスベクター製造市場：用途別市場規模予測 2021年-2026年（遺伝子治療、ワクチン） ・北米のウイルスベクター製造市場分析：米国、カナダ ・ヨーロッパのウイルスベクター製造市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアのウイルスベクター製造市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米のウイルスベクター製造市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカのウイルスベクター製造市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：BioReliance、Cobra Biologics、Oxford BioMedica、UniQure、FinVector、MolMed、MassBiologics、FUJIFILM Diosynth Biotechnologies、Lonza、Biovian、Thermo Fisher Scientific (Brammer Bio) ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Viral vectors represent one of the primary tools, which can be used to deliver the genetic material into cells.
Viral vectors can be utilized in gene therapy for the treatment of different diseases, such as heart defects, metabolic diseases, cancer, and neurodegenerative disorders. Viral vectors based on adenoviruses, adeno-associated viruses, lentiviruses, retroviruses, herpes simplex viruses, baculovirus, etc. are being routinely used in life sciences research and are finding applications in vaccinology and novel drug delivery approaches.
Market Analysis and Insights: Global Viral Vector Manufacturing Market
The global Viral Vector Manufacturing market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Viral Vector Manufacturing Scope and Market Size
Viral Vector Manufacturing market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Viral Vector Manufacturing market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
BioReliance
Cobra Biologics
Oxford BioMedica
UniQure
FinVector
MolMed
MassBiologics
FUJIFILM Diosynth Biotechnologies
Lonza
Biovian
Thermo Fisher Scientific (Brammer Bio)
Market segment by Type, the product can be split into
Adenoviral Vectors
Adeno-associated Viral Vectors
Retroviral Vectors
Lentiviral Vectors
Other
Market segment by Application, split into
Gene Therapy
Vaccinology
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Viral Vector Manufacturing Revenue
1.4 Market by Type
1.4.1 Global Viral Vector Manufacturing Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Adenoviral Vectors
1.4.3 Adeno-associated Viral Vectors
1.4.4 Retroviral Vectors
1.4.5 Lentiviral Vectors
1.4.6 Other
1.5 Market by Application
1.5.1 Global Viral Vector Manufacturing Market Share by Application: 2020 VS 2026
1.5.2 Gene Therapy
1.5.3 Vaccinology
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Viral Vector Manufacturing Market Perspective (2015-2026)
2.2 Global Viral Vector Manufacturing Growth Trends by Regions
2.2.1 Viral Vector Manufacturing Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Viral Vector Manufacturing Historic Market Share by Regions (2015-2020)
2.2.3 Viral Vector Manufacturing Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Viral Vector Manufacturing Market Growth Strategy
2.3.6 Primary Interviews with Key Viral Vector Manufacturing Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Viral Vector Manufacturing Players by Market Size
3.1.1 Global Top Viral Vector Manufacturing Players by Revenue (2015-2020)
3.1.2 Global Viral Vector Manufacturing Revenue Market Share by Players (2015-2020)
3.1.3 Global Viral Vector Manufacturing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Viral Vector Manufacturing Market Concentration Ratio
3.2.1 Global Viral Vector Manufacturing Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Viral Vector Manufacturing Revenue in 2019
3.3 Viral Vector Manufacturing Key Players Head office and Area Served
3.4 Key Players Viral Vector Manufacturing Product Solution and Service
3.5 Date of Enter into Viral Vector Manufacturing Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Viral Vector Manufacturing Historic Market Size by Type (2015-2020)
4.2 Global Viral Vector Manufacturing Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Viral Vector Manufacturing Market Size by Application (2015-2020)
5.2 Global Viral Vector Manufacturing Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Viral Vector Manufacturing Market Size (2015-2020)
6.2 Viral Vector Manufacturing Key Players in North America (2019-2020)
6.3 North America Viral Vector Manufacturing Market Size by Type (2015-2020)
6.4 North America Viral Vector Manufacturing Market Size by Application (2015-2020)
7 Europe
7.1 Europe Viral Vector Manufacturing Market Size (2015-2020)
7.2 Viral Vector Manufacturing Key Players in Europe (2019-2020)
7.3 Europe Viral Vector Manufacturing Market Size by Type (2015-2020)
7.4 Europe Viral Vector Manufacturing Market Size by Application (2015-2020)
8 China
8.1 China Viral Vector Manufacturing Market Size (2015-2020)
8.2 Viral Vector Manufacturing Key Players in China (2019-2020)
8.3 China Viral Vector Manufacturing Market Size by Type (2015-2020)
8.4 China Viral Vector Manufacturing Market Size by Application (2015-2020)
9 Japan
9.1 Japan Viral Vector Manufacturing Market Size (2015-2020)
9.2 Viral Vector Manufacturing Key Players in Japan (2019-2020)
9.3 Japan Viral Vector Manufacturing Market Size by Type (2015-2020)
9.4 Japan Viral Vector Manufacturing Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Viral Vector Manufacturing Market Size (2015-2020)
10.2 Viral Vector Manufacturing Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Viral Vector Manufacturing Market Size by Type (2015-2020)
10.4 Southeast Asia Viral Vector Manufacturing Market Size by Application (2015-2020)
11 India
11.1 India Viral Vector Manufacturing Market Size (2015-2020)
11.2 Viral Vector Manufacturing Key Players in India (2019-2020)
11.3 India Viral Vector Manufacturing Market Size by Type (2015-2020)
11.4 India Viral Vector Manufacturing Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Viral Vector Manufacturing Market Size (2015-2020)
12.2 Viral Vector Manufacturing Key Players in Central & South America (2019-2020)
12.3 Central & South America Viral Vector Manufacturing Market Size by Type (2015-2020)
12.4 Central & South America Viral Vector Manufacturing Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 BioReliance
13.1.1 BioReliance Company Details
13.1.2 BioReliance Business Overview
13.1.3 BioReliance Viral Vector Manufacturing Introduction
13.1.4 BioReliance Revenue in Viral Vector Manufacturing Business (2015-2020))
13.1.5 BioReliance Recent Development
13.2 Cobra Biologics
13.2.1 Cobra Biologics Company Details
13.2.2 Cobra Biologics Business Overview
13.2.3 Cobra Biologics Viral Vector Manufacturing Introduction
13.2.4 Cobra Biologics Revenue in Viral Vector Manufacturing Business (2015-2020)
13.2.5 Cobra Biologics Recent Development
13.3 Oxford BioMedica
13.3.1 Oxford BioMedica Company Details
13.3.2 Oxford BioMedica Business Overview
13.3.3 Oxford BioMedica Viral Vector Manufacturing Introduction
13.3.4 Oxford BioMedica Revenue in Viral Vector Manufacturing Business (2015-2020)
13.3.5 Oxford BioMedica Recent Development
13.4 UniQure
13.4.1 UniQure Company Details
13.4.2 UniQure Business Overview
13.4.3 UniQure Viral Vector Manufacturing Introduction
13.4.4 UniQure Revenue in Viral Vector Manufacturing Business (2015-2020)
13.4.5 UniQure Recent Development
13.5 FinVector
13.5.1 FinVector Company Details
13.5.2 FinVector Business Overview
13.5.3 FinVector Viral Vector Manufacturing Introduction
13.5.4 FinVector Revenue in Viral Vector Manufacturing Business (2015-2020)
13.5.5 FinVector Recent Development
13.6 MolMed
13.6.1 MolMed Company Details
13.6.2 MolMed Business Overview
13.6.3 MolMed Viral Vector Manufacturing Introduction
13.6.4 MolMed Revenue in Viral Vector Manufacturing Business (2015-2020)
13.6.5 MolMed Recent Development
13.7 MassBiologics
13.7.1 MassBiologics Company Details
13.7.2 MassBiologics Business Overview
13.7.3 MassBiologics Viral Vector Manufacturing Introduction
13.7.4 MassBiologics Revenue in Viral Vector Manufacturing Business (2015-2020)
13.7.5 MassBiologics Recent Development
13.8 FUJIFILM Diosynth Biotechnologies
13.8.1 FUJIFILM Diosynth Biotechnologies Company Details
13.8.2 FUJIFILM Diosynth Biotechnologies Business Overview
13.8.3 FUJIFILM Diosynth Biotechnologies Viral Vector Manufacturing Introduction
13.8.4 FUJIFILM Diosynth Biotechnologies Revenue in Viral Vector Manufacturing Business (2015-2020)
13.8.5 FUJIFILM Diosynth Biotechnologies Recent Development
13.9 Lonza
13.9.1 Lonza Company Details
13.9.2 Lonza Business Overview
13.9.3 Lonza Viral Vector Manufacturing Introduction
13.9.4 Lonza Revenue in Viral Vector Manufacturing Business (2015-2020)
13.9.5 Lonza Recent Development
13.10 Biovian
13.10.1 Biovian Company Details
13.10.2 Biovian Business Overview
13.10.3 Biovian Viral Vector Manufacturing Introduction
13.10.4 Biovian Revenue in Viral Vector Manufacturing Business (2015-2020)
13.10.5 Biovian Recent Development
13.11 Thermo Fisher Scientific (Brammer Bio)
10.11.1 Thermo Fisher Scientific (Brammer Bio) Company Details
10.11.2 Thermo Fisher Scientific (Brammer Bio) Business Overview
10.11.3 Thermo Fisher Scientific (Brammer Bio) Viral Vector Manufacturing Introduction
10.11.4 Thermo Fisher Scientific (Brammer Bio) Revenue in Viral Vector Manufacturing Business (2015-2020)
10.11.5 Thermo Fisher Scientific (Brammer Bio) Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Viral Vector Manufacturing Key Market Segments
Table 2. Key Players Covered: Ranking by Viral Vector Manufacturing Revenue
Table 3. Ranking of Global Top Viral Vector Manufacturing Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Viral Vector Manufacturing Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Adenoviral Vectors
Table 6. Key Players of Adeno-associated Viral Vectors
Table 7. Key Players of Retroviral Vectors
Table 8. Key Players of Lentiviral Vectors
Table 9. Key Players of Other
Table 10. Global Viral Vector Manufacturing Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 11. Global Viral Vector Manufacturing Market Size by Regions (US$ Million): 2020 VS 2026
Table 12. Global Viral Vector Manufacturing Market Size by Regions (2015-2020) (US$ Million)
Table 13. Global Viral Vector Manufacturing Market Share by Regions (2015-2020)
Table 14. Global Viral Vector Manufacturing Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 15. Global Viral Vector Manufacturing Market Share by Regions (2021-2026)
Table 16. Market Top Trends
Table 17. Key Drivers: Impact Analysis
Table 18. Key Challenges
Table 19. Viral Vector Manufacturing Market Growth Strategy
Table 20. Main Points Interviewed from Key Viral Vector Manufacturing Players
Table 21. Global Viral Vector Manufacturing Revenue by Players (2015-2020) (Million US$)
Table 22. Global Viral Vector Manufacturing Market Share by Players (2015-2020)
Table 23. Global Top Viral Vector Manufacturing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Viral Vector Manufacturing as of 2019)
Table 24. Global Viral Vector Manufacturing by Players Market Concentration Ratio (CR5 and HHI)
Table 25. Key Players Headquarters and Area Served
Table 26. Key Players Viral Vector Manufacturing Product Solution and Service
Table 27. Date of Enter into Viral Vector Manufacturing Market
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Viral Vector Manufacturing Market Size by Type (2015-2020) (Million US$)
Table 30. Global Viral Vector Manufacturing Market Size Share by Type (2015-2020)
Table 31. Global Viral Vector Manufacturing Revenue Market Share by Type (2021-2026)
Table 32. Global Viral Vector Manufacturing Market Size Share by Application (2015-2020)
Table 33. Global Viral Vector Manufacturing Market Size by Application (2015-2020) (Million US$)
Table 34. Global Viral Vector Manufacturing Market Size Share by Application (2021-2026)
Table 35. North America Key Players Viral Vector Manufacturing Revenue (2019-2020) (Million US$)
Table 36. North America Key Players Viral Vector Manufacturing Market Share (2019-2020)
Table 37. North America Viral Vector Manufacturing Market Size by Type (2015-2020) (Million US$)
Table 38. North America Viral Vector Manufacturing Market Share by Type (2015-2020)
Table 39. North America Viral Vector Manufacturing Market Size by Application (2015-2020) (Million US$)
Table 40. North America Viral Vector Manufacturing Market Share by Application (2015-2020)
Table 41. Europe Key Players Viral Vector Manufacturing Revenue (2019-2020) (Million US$)
Table 42. Europe Key Players Viral Vector Manufacturing Market Share (2019-2020)
Table 43. Europe Viral Vector Manufacturing Market Size by Type (2015-2020) (Million US$)
Table 44. Europe Viral Vector Manufacturing Market Share by Type (2015-2020)
Table 45. Europe Viral Vector Manufacturing Market Size by Application (2015-2020) (Million US$)
Table 46. Europe Viral Vector Manufacturing Market Share by Application (2015-2020)
Table 47. China Key Players Viral Vector Manufacturing Revenue (2019-2020) (Million US$)
Table 48. China Key Players Viral Vector Manufacturing Market Share (2019-2020)
Table 49. China Viral Vector Manufacturing Market Size by Type (2015-2020) (Million US$)
Table 50. China Viral Vector Manufacturing Market Share by Type (2015-2020)
Table 51. China Viral Vector Manufacturing Market Size by Application (2015-2020) (Million US$)
Table 52. China Viral Vector Manufacturing Market Share by Application (2015-2020)
Table 53. Japan Key Players Viral Vector Manufacturing Revenue (2019-2020) (Million US$)
Table 54. Japan Key Players Viral Vector Manufacturing Market Share (2019-2020)
Table 55. Japan Viral Vector Manufacturing Market Size by Type (2015-2020) (Million US$)
Table 56. Japan Viral Vector Manufacturing Market Share by Type (2015-2020)
Table 57. Japan Viral Vector Manufacturing Market Size by Application (2015-2020) (Million US$)
Table 58. Japan Viral Vector Manufacturing Market Share by Application (2015-2020)
Table 59. Southeast Asia Key Players Viral Vector Manufacturing Revenue (2019-2020) (Million US$)
Table 60. Southeast Asia Key Players Viral Vector Manufacturing Market Share (2019-2020)
Table 61. Southeast Asia Viral Vector Manufacturing Market Size by Type (2015-2020) (Million US$)
Table 62. Southeast Asia Viral Vector Manufacturing Market Share by Type (2015-2020)
Table 63. Southeast Asia Viral Vector Manufacturing Market Size by Application (2015-2020) (Million US$)
Table 64. Southeast Asia Viral Vector Manufacturing Market Share by Application (2015-2020)
Table 65. India Key Players Viral Vector Manufacturing Revenue (2019-2020) (Million US$)
Table 66. India Key Players Viral Vector Manufacturing Market Share (2019-2020)
Table 67. India Viral Vector Manufacturing Market Size by Type (2015-2020) (Million US$)
Table 68. India Viral Vector Manufacturing Market Share by Type (2015-2020)
Table 69. India Viral Vector Manufacturing Market Size by Application (2015-2020) (Million US$)
Table 70. India Viral Vector Manufacturing Market Share by Application (2015-2020)
Table 71. Central & South America Key Players Viral Vector Manufacturing Revenue (2019-2020) (Million US$)
Table 72. Central & South America Key Players Viral Vector Manufacturing Market Share (2019-2020)
Table 73. Central & South America Viral Vector Manufacturing Market Size by Type (2015-2020) (Million US$)
Table 74. Central & South America Viral Vector Manufacturing Market Share by Type (2015-2020)
Table 75. Central & South America Viral Vector Manufacturing Market Size by Application (2015-2020) (Million US$)
Table 76. Central & South America Viral Vector Manufacturing Market Share by Application (2015-2020)
Table 77. BioReliance Company Details
Table 78. BioReliance Business Overview
Table 79. BioReliance Product
Table 80. BioReliance Revenue in Viral Vector Manufacturing Business (2015-2020) (Million US$)
Table 81. BioReliance Recent Development
Table 82. Cobra Biologics Company Details
Table 83. Cobra Biologics Business Overview
Table 84. Cobra Biologics Product
Table 85. Cobra Biologics Revenue in Viral Vector Manufacturing Business (2015-2020) (Million US$)
Table 86. Cobra Biologics Recent Development
Table 87. Oxford BioMedica Company Details
Table 88. Oxford BioMedica Business Overview
Table 89. Oxford BioMedica Product
Table 90. Oxford BioMedica Revenue in Viral Vector Manufacturing Business (2015-2020) (Million US$)
Table 91. Oxford BioMedica Recent Development
Table 92. UniQure Company Details
Table 93. UniQure Business Overview
Table 94. UniQure Product
Table 95. UniQure Revenue in Viral Vector Manufacturing Business (2015-2020) (Million US$)
Table 96. UniQure Recent Development
Table 97. FinVector Company Details
Table 98. FinVector Business Overview
Table 99. FinVector Product
Table 100. FinVector Revenue in Viral Vector Manufacturing Business (2015-2020) (Million US$)
Table 101. FinVector Recent Development
Table 102. MolMed Company Details
Table 103. MolMed Business Overview
Table 104. MolMed Product
Table 105. MolMed Revenue in Viral Vector Manufacturing Business (2015-2020) (Million US$)
Table 106. MolMed Recent Development
Table 107. MassBiologics Company Details
Table 108. MassBiologics Business Overview
Table 109. MassBiologics Product
Table 110. MassBiologics Revenue in Viral Vector Manufacturing Business (2015-2020) (Million US$)
Table 111. MassBiologics Recent Development
Table 112. FUJIFILM Diosynth Biotechnologies Business Overview
Table 113. FUJIFILM Diosynth Biotechnologies Product
Table 114. FUJIFILM Diosynth Biotechnologies Company Details
Table 115. FUJIFILM Diosynth Biotechnologies Revenue in Viral Vector Manufacturing Business (2015-2020) (Million US$)
Table 116. FUJIFILM Diosynth Biotechnologies Recent Development
Table 117. Lonza Company Details
Table 118. Lonza Business Overview
Table 119. Lonza Product
Table 120. Lonza Revenue in Viral Vector Manufacturing Business (2015-2020) (Million US$)
Table 121. Lonza Recent Development
Table 122. Biovian Company Details
Table 123. Biovian Business Overview
Table 124. Biovian Product
Table 125. Biovian Revenue in Viral Vector Manufacturing Business (2015-2020) (Million US$)
Table 126. Biovian Recent Development
Table 127. Thermo Fisher Scientific (Brammer Bio) Company Details
Table 128. Thermo Fisher Scientific (Brammer Bio) Business Overview
Table 129. Thermo Fisher Scientific (Brammer Bio) Product
Table 130. Thermo Fisher Scientific (Brammer Bio) Revenue in Viral Vector Manufacturing Business (2015-2020) (Million US$)
Table 131. Thermo Fisher Scientific (Brammer Bio) Recent Development
Table 132. Research Programs/Design for This Report
Table 133. Key Data Information from Secondary Sources
Table 134. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Viral Vector Manufacturing Market Share by Type: 2020 VS 2026
Figure 2. Adenoviral Vectors Features
Figure 3. Adeno-associated Viral Vectors Features
Figure 4. Retroviral Vectors Features
Figure 5. Lentiviral Vectors Features
Figure 6. Other Features
Figure 7. Global Viral Vector Manufacturing Market Share by Application: 2020 VS 2026
Figure 8. Gene Therapy Case Studies
Figure 9. Vaccinology Case Studies
Figure 10. Viral Vector Manufacturing Report Years Considered
Figure 11. Global Viral Vector Manufacturing Market Size YoY Growth 2015-2026 (US$ Million)
Figure 12. Global Viral Vector Manufacturing Market Share by Regions: 2020 VS 2026
Figure 13. Global Viral Vector Manufacturing Market Share by Regions (2021-2026)
Figure 14. Porter's Five Forces Analysis
Figure 15. Global Viral Vector Manufacturing Market Share by Players in 2019
Figure 16. Global Top Viral Vector Manufacturing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Viral Vector Manufacturing as of 2019
Figure 17. The Top 10 and 5 Players Market Share by Viral Vector Manufacturing Revenue in 2019
Figure 18. North America Viral Vector Manufacturing Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Europe Viral Vector Manufacturing Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. China Viral Vector Manufacturing Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Japan Viral Vector Manufacturing Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Southeast Asia Viral Vector Manufacturing Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. India Viral Vector Manufacturing Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Central & South America Viral Vector Manufacturing Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Bottom-up and Top-down Approaches for This Report
Figure 26. Data Triangulation
Figure 27. Key Executives Interviewed
ウイルス不活化の世界市場（～2026年） Viral inactivation is important and mandatory step in the manufacturing process of biological products to remove or inactivate potential contaminant viruses. These biological products are used for the treatment and diagnostic purposes in humans. Estimates of their viral inactivation market segment r…- ウイルス性結膜炎治療薬の世界市場（～2026年） Viral conjunctivitis therapeutics is undergoing a transitional phase. Currently, there is no drug available for the treatment of viral conjunctivitis. However, the presence of a robust pipeline indicates towards a thriving future. The global market for viral conjunctivitis pipeline drugs is likely t…
- 酵母発現ベクターの世界市場（～2026年） Market Analysis and Insights: Global Yeast Expression Vector Market The global Yeast Expression Vector market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Yeast Expression Vector Scope and Market Size Yeast Expression Vect…
- ウイルスクリアランスの世界市場（～2026年） The viral clearance market in the region is driven by the presence of national institutes supporting biotechnology and life science research, growth in the pharmaceuticals industry, and the increasing number of drug approvals. While this is a high-growth market, the high time and cost requirements f…
- ウイルス分子診断の世界市場（～2026年） Molecular diagnostics refers to a technique used to detect and identify the presence of genetic material or proteins associated with a specific health condition or disease. North America, followed by Europe, has the largest market for viral molecular diagnostics due to developed healthcare infrastru…